These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 10402001

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
    Kim SY, Kim JS, Yi JS, Lee JH, Choi SH, Nam SY, Cho KJ, Lee SW, Kim SB, Roh JL.
    Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
    [Abstract] [Full Text] [Related]

  • 31. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
    Paulus P, Sambon A, Vivegnis D, Hustinx R, Moreau P, Collignon J, Deneufbourg JM, Rigo P.
    Laryngoscope; 1998 Oct; 108(10):1578-83. PubMed ID: 9778305
    [Abstract] [Full Text] [Related]

  • 32. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Li CY, Klohr S, Sadick H, Weiss C, Hoermann K, Schoenberg SO, Sadick M.
    J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
    [Abstract] [Full Text] [Related]

  • 33. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP, Hüllner M, Mader CE, Kastrinidis N, Huber GF, von Schulthess GK, Kollias S, Veit-Haibach P.
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [Abstract] [Full Text] [Related]

  • 34. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
    Yao M, Smith RB, Graham MM, Hoffman HT, Tan H, Funk GF, Graham SM, Chang K, Dornfeld KJ, Menda Y, Buatti JM.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):991-9. PubMed ID: 16099601
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison of diffusion-weighted MR imaging and 18F Fluorodeoxyglucose PET/CT in detection of residual or recurrent tumors and delineation of their local spread after (chemo) radiotherapy for head and neck squamous cell carcinoma.
    Schroeder C, Lee JH, Tetzner U, Seidel S, Kim SY.
    Eur J Radiol; 2020 Sep 15; 130():109157. PubMed ID: 32652403
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.